Skip to main content
. 2008 Jun 29;23(9):1361–1366. doi: 10.1007/s11606-008-0656-3

Table 1.

Baseline Demographic, Psychological, and Smoking-Related Characteristics for Total Sample and Among Treatment Judgment Groups

  Total (n = 512) Judged bupropion (n = 253) Judged placebo (n = 167) Judged uncertain (n = 66)
Age, mean (SD) 44.7 (11.2) 45.2 (12.0) 43.9 (9.7) 44.6 (11.7)
Female (n, %) 351(68.6%) 170 (67.2%) 115 (68.9%) 66 (71.7%)
Weight (kg), mean (SD) 183.9 (46.6) 182.5 (47.4) 186.8 (47.4) 82.8 (19.5)
≤High school graduate, n (%) 248 (48.4%) 120 (47.4%) 79 (47.3%) 49 (53.3%)
aMonthly income <$1,800, n (%) 276 (54.8%) 139 (55.9%)a 74 (45.1%)a 63 (69.2%)a
Married or cohabitating, n (%) 193 (37.7%) 95 (37.6%)b 73 (43.7%)b 25 (27.2%)b
Menthol, n (%) 396 (77.3%) 193 (76.3%) 135 (80.8%) 68 (73.9%)
CPD, mean (SD) 19.0 (8.1) 19.0 (8.1) 19.3 (7.8) 18.8 (8.3)
bSalivary cotinine (ng/ml), mean (SD) 288.9 (144.2) 277.0 (137.5)c 311.4 (150.7)c 280.3 (147.1)c
FTND, mean (SD) 4.6 (2.0) 4.5 (2.0) 4.5 (2.1) 4.8 (2.0)
Previous quits, mean (SD) 2.5 (4.9) 2.7 (5.0) 2.4 (5.4) 2.0 (3.1)
Previous use of sustained-release bupropion, n (%) 40 (7.8%) 18 (7.1%) 10 (6.0%) 12 (13.0%)

ap < 0.001;

bp = 0.032;

cp < 0.047

CPD = cigarettes per day

FTND = Fagerstrom Test for Nicotine Dependence score33